517MO Phase I study of the porcupine (PORCN) inhibitor RXC004 in patients with advanced solid tumours
Natalie Cook, Sarah P. Blagden, Juanita Lopez, Debashis Sarker, Alastair Greystoke, Neil Harris, Farasat Kazmi, Azam Naderi, George Nintos, Adele Franco, Rille Pihlak, R. Shinde, Louise Goodwin, Caroline Phillips, Jane Robertson, A. Saunders, Craig Tilston, Simon A. Woodcock, Ruth Plummer
Topics & Concepts
MedicineAdverse effectDysgeusiaNauseaWnt signaling pathwayInternal medicineTolerabilityOncologyPharmacologyGastroenterologySignal transductionBiochemistryChemistryAdvanced Breast Cancer TherapiesColorectal Cancer Treatments and StudiesCancer-related Molecular Pathways